发明名称 Cysteamines for treating complications of hypercholesterolemia and diabetes
摘要 The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat hypercholesterolemia and/or complications associated with hypercholesterolemia. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of diabetes in an at-risk patient and/or treat or prevent the onset of diabetes-associated complications.
申请公布号 AU2005240122(A1) 申请公布日期 2005.11.17
申请号 AU20050240122 申请日期 2005.04.29
申请人 OMEGA BIO-PHARMA (I.P.3) LIMITED 发明人 JINXIAN XU;FRANCIS CHI;GARY KWAN PO WONG;BILL PIU CHAN
分类号 A61K31/095;A61K31/13;A61K31/426;A61K31/4439;A61K38/28;A61K47/48;A61K51/12;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/00;A61P43/00 主分类号 A61K31/095
代理机构 代理人
主权项
地址